| 1例恶性水肿型皮肤炭疽患者的药学监护 |
| |
| 引用本文： | 袁海玲,谢华,魏国一,赵静,路宁维,张文. 1例恶性水肿型皮肤炭疽患者的药学监护[J]. 中国现代应用药学, 2016, 33(5): 660-664 |
| |
| 作者姓名： | 袁海玲 谢华 魏国一 赵静 路宁维 张文 |
| |
| 作者单位： | 兰州军区兰州总医院安宁分院药剂科，兰州 730070,兰州军区兰州总医院安宁分院药剂科，兰州 730071,兰州军区兰州总医院安宁分院药剂科，兰州 730072,兰州军区兰州总医院安宁分院药剂科，兰州 730073,兰州军区兰州总医院安宁分院药剂科，兰州 730074,兰州军区兰州总医院安宁分院药剂科，兰州 730075 |
| |
| 摘 要： | 目的 探讨临床药师对恶性水肿型皮肤炭疽患者的药学监护模式。方法 根据恶性水肿型皮肤炭疽患者的药物治疗特点，对患者进行药学监护，针对性提出用药建议。结果 通过药学监护，可提高恶性水肿型皮肤炭疽患者用药的安全性、合理性及有效性，减少药物不良反应的发生。结论 临床药师积极开展药学服务，协同临床医师优化给药方案，有利于患者用药安全、合理、有效。
|
| 关 键 词： | 皮肤炭疽；临床药师；药学监护 |
| 收稿时间： | 2015-10-24 |
| 修稿时间： | 2015-12-24 |
Pharmaceutical Care for a Patient with Cutaneous Anthrax of Malignant Edema |
| |
| YUAN Hailing,XIE Hu,WEI Guoyi,ZHAO Jing,LU Ningwei and ZHANG Wen. Pharmaceutical Care for a Patient with Cutaneous Anthrax of Malignant Edema[J]. The Chinese Journal of Modern Applied Pharmacy, 2016, 33(5): 660-664 |
| |
| Authors: | YUAN Hailing XIE Hu WEI Guoyi ZHAO Jing LU Ningwei ZHANG Wen |
| |
| Affiliation: | Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730070, China,Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730071, China,Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730072, China,Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730073, China,Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730074, China and Department of Pharmacy, Anning Branch Lanzhou General Hospital Lanzhou Command, Lanzhou 730075, China |
| |
| Abstract: | OBJECTIVE To discuss the pharmaceutical care model on the patient with cutaneous anthrax of malignant edema. METHODS According to the characteristics of drug therapy on the patient with cutaneous anthrax of malignant edema, the pharmaceutical care was carried out and the suggestions on the pharmacy were given. RESULTS Through the pharmaceutical care, the safety, reasonable and effectiveness were improved. And also, the incidence rate of adverse drug reaction was decreased. CONCLUSION The clinical pharmacists develop actively pharmaceutical service and optimize dosage regimen cooperating with the clinical physician, which is beneficial to the safety, reasonable and effectiveness of drug therapy on the patients. |
| |
| Keywords: | cutaneous anthrax clinical pharmacist pharmaceutical care |
|
| 点击此处可从《中国现代应用药学》浏览原始摘要信息 |
|
点击此处可从《中国现代应用药学》下载全文 |
|
